《Kidney International》新冠之年的肾移植专刊解读
本文概述《Kidney International》2020年12月期多篇文章,聚焦2020年2至6月新冠疫情对全球肾移植受者及移植项目的影响,涉及风险、结局、流行病学与潜在治疗,并与1665年伦敦瘟疫历史记载类比。
要点
- 疫情对肾移植受者及移植项目的风险、结局与流行病学已被多项研究详细报道
- 潜在治疗与感染流行病学是疫情期肾移植管理的关注重点
- 历史瘟疫记载与新冠疫情防控措施及人类反应具有相似性
核心结论
- 2020年2至6月新冠疫情对全球肾移植受者及移植项目的影响已在《Kidney International》12月期多篇文章中详细研究。
主要发现
- 多个研究者详细研究了过去12个月全球肾移植人群的风险、结局、流行病学与潜在治疗。
- 1665年伦敦瘟疫记载中的未证实治疗、感染流行病学与封城限制的人类反应与当前疫情表现相似。
临床怎么用
- 肾移植临床应关注疫情期受者的感染风险、结局与潜在治疗证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The global coronavirus disease 2019 pandemic's impact on kidney transplant recipients and transplantation programs in the calamitous months of February to June 2020, spring to summer in the Northern Hemisphere, is represented in articles published in the December issue of Kidney International. Writing about another pandemic in the year of 1665 over 300 years ago, the author Daniel Defoe1 describes the same period of time in London and gives a remarkably familiar description of how a pandemic affects populations, including the unproven treatments, epidemiology of infection, and human response to restrictions on freedom of city lockdowns that occurred during that time. The risks, outcomes, epidemiology, and potential treatments for the kidney transplant population worldwide during the past 12 months have been thankfully studied in detail by multiple investigators and form the subject of papers in KI this month.
引用
- Coates PT. A Kidney International "journal of the COVID-19 year" in kidney transplantation. Kidney Int. 2020. PMID: 33091436. doi:10.1016/j.kint.2020.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。